WO2008104032A1 - Body wrap with sodium carbonate dosage pack - Google Patents

Body wrap with sodium carbonate dosage pack Download PDF

Info

Publication number
WO2008104032A1
WO2008104032A1 PCT/AU2008/000273 AU2008000273W WO2008104032A1 WO 2008104032 A1 WO2008104032 A1 WO 2008104032A1 AU 2008000273 W AU2008000273 W AU 2008000273W WO 2008104032 A1 WO2008104032 A1 WO 2008104032A1
Authority
WO
WIPO (PCT)
Prior art keywords
sodium carbonate
sheet material
absorbent sheet
wrap
dosage
Prior art date
Application number
PCT/AU2008/000273
Other languages
French (fr)
Inventor
Ben Mcmurtrie
John Wright Skelley
Original Assignee
D-Swell Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2007901059A external-priority patent/AU2007901059A0/en
Application filed by D-Swell Pty Ltd filed Critical D-Swell Pty Ltd
Publication of WO2008104032A1 publication Critical patent/WO2008104032A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A61F13/06—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings
    • A61F13/061—Bandages or dressings; Absorbent pads specially adapted for feet or legs; Corn-pads; Corn-rings for knees
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
    • A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow

Definitions

  • the present invention relates to a body wrap, for example, a knee wrap.
  • soda crystals also known as sodium carbonate decahydrate and hydrated sodium carbonate
  • topical application of soda crystals to the human knee reduces swelling and relieves pain of injury, surgery, or disease.
  • soda crystals also known as sodium carbonate decahydrate and hydrated sodium carbonate
  • a stocking, pillowcase or sock is filled with soda crystals and wrapped around the knee.
  • makeshift arrangements are inconvenient to use on a regular and extended basis because skin temperature melts the soda crystals, and the resulting sodium carbonate solution leaks away from the knee to where it can have no swelling reduction and/or pain relief benefit.
  • knee wrap which provides controlled and sustained topical release of sodium carbonate solution around the knee, and which retains the sodium carbonate solution on the skin of the knee where it can have a swelling reduction and/or pain relief benefit. It would be of further benefit to provide a knee wrap which provides compression to help stabilise the soft tissues about the knee during the controlled and sustained topical release of sodium carbonate solution.
  • a body wrap including at least one dosage pack retained on one side of absorbent sheet material having a length sufficient to wrap around a body part, wherein the at least one dosage pack contains a liquefiable and/or liquefied topical dosage form of sodium carbonate, and wherein wrapping the absorbent sheet material around the body part with the at least one dosage pack against the body part generates a sustained-release topical dosage of sodium carbonate solution which is retained in position around the body part by the absorbent sheet material.
  • the liquefiable and/or liquefied topical dosage form of sodium carbonate can be selected from sodium carbonate decahydrate crystals, aqueous solutions of sodium carbonate, flowable compositions of sodium carbonate, and combinations thereof.
  • the at least one dosage pack can have at least one liquid permeable surface or at least one opening through which the sustained-release topical dosage of sodium carbonate solution is released.
  • the at least one liquid permeable surface or at least one opening can be selectively liquidly sealed by at least one removable seal.
  • At least one end of the absorbent sheet material can have at least one elasticised strap to compressively wrap the absorbent sheet material around the body part.
  • the at least one elasticised strap can be releasably fastenable to itself.
  • the absorbent sheet material can be rectangular with a length sufficient to wrap around a knee.
  • Figure 1 is a plan view of a body wrap of one embodiment of the invention
  • Figure 2 is a partial side section through the body wrap
  • Figure 3 is a perspective view of the body wrap wrapped around a knee
  • Figure 4 is a section through the body wrap in position around the knee.
  • FIG. 1 illustrates a body wrap 10 of one embodiment of the invention configured as a knee wrap. It will be appreciated that other embodiments of the invention may also be configured to wrap other parts and/or joints of a body, for example, ankles, elbows, wrists, etc.
  • the knee wrap 10 includes dosage packs 12 retained on one side of a rectangular, absorbent sheet material 14 having a length sufficient to wrap around a knee.
  • the dosage packs 12 are provided as an integral array.
  • the dosage packs 12 may also be provided on the absorbent sheet material 14 as individually separate and distinct elements.
  • Two elasticised straps 16 are attached to one end of the absorbent sheet material 14. Releasable fastening tabs 18 are provided on the free ends of the elasticised straps 16.
  • the elasticised straps 16 also have visual compression indicators (not shown) distributed over their length to indicate the compressive force applied when they are stretched around a knee.
  • the compression indicators are rectangles that transform into squares when a predetermined compressive force is applied by stretching the elasticised straps 16.
  • the absorbent sheet material 14 is made, for example, of a nonwoven fabric containing super absorbent fibres and cellulose fibres.
  • the elasticised straps 16 are made, for example, of elasticised nonwoven fabric.
  • the tabs 18 are, for example, hook fasteners that releasably fasten to the elasticised straps 16.
  • the components of the wrap 10 are attached by, for example, fusing, sewing and/or gluing.
  • the knee wrap 10 is provided as a disposable product and is packaged, for example, in a sealed polyethylene laminate barrier bag (not shown). Other equivalent materials and constructions may also be used for the knee wrap 10.
  • the dosage packs 12 contain a liquefiable and/or liquefied topical dosage form of sodium carbonate, for example, sodium carbonate decahydrate crystals 24.
  • the sodium carbonate decahydrate crystals 24 are alkaline crystals that endothermically melt at a melting point between around 32 and 33 degrees Centigrade.
  • sodium carbonate decahydrate crystals 24 often have poor flow properties since the crystals 24 may form larger aggregates during storage, handling and manufacturing of the dosage packs 12.
  • the topical dosage form of sodium carbonate is selected from sodium carbonate decahydrate crystals 24 alone, sodium carbonate decahydrate crystals 24 distributed in a viscous carrier gel or cream, sodium carbonate decahydrate crystals 24 in an aqueous solution with water additional to the water of crystallisation, sodium carbonate solution, and combinations thereof.
  • the dosage packs 12 are each constituted by a skin facing layer 20 and a liquid impermeable layer 22 adjacent to the absorbent sheet material 14.
  • the skin facing layer 20 is selectively liquidly sealed before use by a removable seal (not shown).
  • the skin facing layer 20 is a liquid permeable material, for example, a liquid permeable nonwoven fabric.
  • the removable seal is, for example, a removable liquid impermeable plastic film that sealingly covers the liquid permeable surface area of the skin facing layer 20.
  • the skin facing layer 20 is a liquid impermeable material, for example, a liquid impermeable plastic.
  • the skin facing layer 20 has one or more openings or perforations (not shown) that are sealingly covered before use by the removable seal.
  • the openings or perforations are configured to provide controlled and sustained release of sodium carbonate solution from the dosage packs 12.
  • microperforations and/or a low perforation filter are provided to control the rate of sustained- release of sodium carbonate solution from the dosage packs 12, as well as filtering impurities and/or particulates from the sodium carbonate solution.
  • the removable seals (not shown) are first removed from the skin facing layer 20 of the dosage packs 12.
  • the absorbent sheet material 14 is then conformably wrapped around the knee with the dosage packs 12 against the skin of the knee.
  • the absorbent sheet material 14 and the dosage packs 12 are compressively fastened around the knee by wrapping the elasticised straps 16 around the absorbent sheet material 14 and fastening the tabs 18 to the elasticised straps 16 themselves.
  • the elasticised straps 16 are stretched until the rectangular compression indicators are transformed into squares so as to indicate that an appropriate predetermined compressive force has been applied to the soft tissues of the knee.
  • the dosage packs 12 compressively positioned over the soft tissues of the knee then generate a sustained-release topical dosage of sodium carbonate solution which is retained in position around the knee by the absorbent sheet material.
  • the dosage packs 12 contain sodium carbonate decahydrate crystals 24, the skin temperature at the knee is typically at, or soon reaches, around the melting point of the crystals 24 so that they begin to at least partially melt and liquefy.
  • the local skin temperature ranges between around 27 and 37 degrees Centigrade.
  • the dosage packs 12 therefore bathe the skin and soft tissues of the knee with alkaline sodium carbonate solution, whereupon the absorbent sheet material 14 retains the sodium carbonate solution in position to create an alkaline environment around the skin and soft tissues of the knee.
  • the elastic straps 16 provide compression to help stabilise the soft tissues about the knee while the skin of the knee is bathed with the sodium carbonate solution.
  • the alkalinity of the sodium carbonate solution may have a swelling reduction and/or pain relief benefit. It is also believed that cooling of the soft tissues about the knee resulting from endothermic melting of sodium carbonate decahydrate crystals 24 may contribute to the swelling reduction and/or pain relief benefit.
  • RICE rest, ice, compression, and elevation

Abstract

A body wrap including at least one dosage pack retained on one side of absorbent sheet material having a length sufficient to wrap around a body part, wherein the at least one dosage pack contains a liquefiable and/or liquefied topical dosage form of sodium carbonate, and wherein wrapping the absorbent sheet material around the body part with the at least one dosage pack against the body part generates a sustained-release topical dosage of sodium carbonate solution which is retained in position around the body part by the absorbent sheet material.

Description

BODY WRAP WITH SODIUM CARBONATE DOSAGE PACK
FIELD OF THE INVENTION
The present invention relates to a body wrap, for example, a knee wrap.
BACKGROUND OF THE INVENTION
Anecdotally, it has been suggested that topical application of soda crystals (also known as sodium carbonate decahydrate and hydrated sodium carbonate) to the human knee reduces swelling and relieves pain of injury, surgery, or disease. Commonly, a stocking, pillowcase or sock is filled with soda crystals and wrapped around the knee. However, such makeshift arrangements are inconvenient to use on a regular and extended basis because skin temperature melts the soda crystals, and the resulting sodium carbonate solution leaks away from the knee to where it can have no swelling reduction and/or pain relief benefit.
What is needed is a knee wrap which provides controlled and sustained topical release of sodium carbonate solution around the knee, and which retains the sodium carbonate solution on the skin of the knee where it can have a swelling reduction and/or pain relief benefit. It would be of further benefit to provide a knee wrap which provides compression to help stabilise the soft tissues about the knee during the controlled and sustained topical release of sodium carbonate solution.
SUMMARY OF THE INVENTION
According to the present invention, there is provided a body wrap including at least one dosage pack retained on one side of absorbent sheet material having a length sufficient to wrap around a body part, wherein the at least one dosage pack contains a liquefiable and/or liquefied topical dosage form of sodium carbonate, and wherein wrapping the absorbent sheet material around the body part with the at least one dosage pack against the body part generates a sustained-release topical dosage of sodium carbonate solution which is retained in position around the body part by the absorbent sheet material.
The liquefiable and/or liquefied topical dosage form of sodium carbonate can be selected from sodium carbonate decahydrate crystals, aqueous solutions of sodium carbonate, flowable compositions of sodium carbonate, and combinations thereof.
The at least one dosage pack can have at least one liquid permeable surface or at least one opening through which the sustained-release topical dosage of sodium carbonate solution is released.
The at least one liquid permeable surface or at least one opening can be selectively liquidly sealed by at least one removable seal.
At least one end of the absorbent sheet material can have at least one elasticised strap to compressively wrap the absorbent sheet material around the body part.
The at least one elasticised strap can be releasably fastenable to itself.
The absorbent sheet material can be rectangular with a length sufficient to wrap around a knee.
BRIEF DESCRIPTION OF THE DRAWINGS
The invention will be further described by way of example only with reference to the accompanying drawings, in which:
Figure 1 is a plan view of a body wrap of one embodiment of the invention; Figure 2 is a partial side section through the body wrap; Figure 3 is a perspective view of the body wrap wrapped around a knee; and
Figure 4 is a section through the body wrap in position around the knee. DETAILED DESCRIPTION
Figure 1 illustrates a body wrap 10 of one embodiment of the invention configured as a knee wrap. It will be appreciated that other embodiments of the invention may also be configured to wrap other parts and/or joints of a body, for example, ankles, elbows, wrists, etc. The knee wrap 10 includes dosage packs 12 retained on one side of a rectangular, absorbent sheet material 14 having a length sufficient to wrap around a knee. The dosage packs 12 are provided as an integral array. The dosage packs 12 may also be provided on the absorbent sheet material 14 as individually separate and distinct elements. Two elasticised straps 16 are attached to one end of the absorbent sheet material 14. Releasable fastening tabs 18 are provided on the free ends of the elasticised straps 16. The elasticised straps 16 also have visual compression indicators (not shown) distributed over their length to indicate the compressive force applied when they are stretched around a knee. For example, the compression indicators are rectangles that transform into squares when a predetermined compressive force is applied by stretching the elasticised straps 16.
The absorbent sheet material 14 is made, for example, of a nonwoven fabric containing super absorbent fibres and cellulose fibres. The elasticised straps 16 are made, for example, of elasticised nonwoven fabric. The tabs 18 are, for example, hook fasteners that releasably fasten to the elasticised straps 16. The components of the wrap 10 are attached by, for example, fusing, sewing and/or gluing. The knee wrap 10 is provided as a disposable product and is packaged, for example, in a sealed polyethylene laminate barrier bag (not shown). Other equivalent materials and constructions may also be used for the knee wrap 10.
The dosage packs 12 contain a liquefiable and/or liquefied topical dosage form of sodium carbonate, for example, sodium carbonate decahydrate crystals 24. The sodium carbonate decahydrate crystals 24 are alkaline crystals that endothermically melt at a melting point between around 32 and 33 degrees Centigrade. However, sodium carbonate decahydrate crystals 24 often have poor flow properties since the crystals 24 may form larger aggregates during storage, handling and manufacturing of the dosage packs 12. Based on these considerations, the topical dosage form of sodium carbonate is selected from sodium carbonate decahydrate crystals 24 alone, sodium carbonate decahydrate crystals 24 distributed in a viscous carrier gel or cream, sodium carbonate decahydrate crystals 24 in an aqueous solution with water additional to the water of crystallisation, sodium carbonate solution, and combinations thereof.
The dosage packs 12 are each constituted by a skin facing layer 20 and a liquid impermeable layer 22 adjacent to the absorbent sheet material 14. The skin facing layer 20 is selectively liquidly sealed before use by a removable seal (not shown). In one embodiment, the skin facing layer 20 is a liquid permeable material, for example, a liquid permeable nonwoven fabric. In this embodiment, the removable seal is, for example, a removable liquid impermeable plastic film that sealingly covers the liquid permeable surface area of the skin facing layer 20. In an alternative embodiment, the skin facing layer 20 is a liquid impermeable material, for example, a liquid impermeable plastic. In this alternative embodiment, the skin facing layer 20 has one or more openings or perforations (not shown) that are sealingly covered before use by the removable seal. The openings or perforations are configured to provide controlled and sustained release of sodium carbonate solution from the dosage packs 12. For example, microperforations and/or a low perforation filter (not shown) are provided to control the rate of sustained- release of sodium carbonate solution from the dosage packs 12, as well as filtering impurities and/or particulates from the sodium carbonate solution.
To use the knee wrap 10, the removable seals (not shown) are first removed from the skin facing layer 20 of the dosage packs 12. Referring to Figures 3 and 4, the absorbent sheet material 14 is then conformably wrapped around the knee with the dosage packs 12 against the skin of the knee. The absorbent sheet material 14 and the dosage packs 12 are compressively fastened around the knee by wrapping the elasticised straps 16 around the absorbent sheet material 14 and fastening the tabs 18 to the elasticised straps 16 themselves. The elasticised straps 16 are stretched until the rectangular compression indicators are transformed into squares so as to indicate that an appropriate predetermined compressive force has been applied to the soft tissues of the knee. The dosage packs 12 compressively positioned over the soft tissues of the knee then generate a sustained-release topical dosage of sodium carbonate solution which is retained in position around the knee by the absorbent sheet material. For example, when the dosage packs 12 contain sodium carbonate decahydrate crystals 24, the skin temperature at the knee is typically at, or soon reaches, around the melting point of the crystals 24 so that they begin to at least partially melt and liquefy. For example, the local skin temperature ranges between around 27 and 37 degrees Centigrade.
The dosage packs 12 therefore bathe the skin and soft tissues of the knee with alkaline sodium carbonate solution, whereupon the absorbent sheet material 14 retains the sodium carbonate solution in position to create an alkaline environment around the skin and soft tissues of the knee. The elastic straps 16 provide compression to help stabilise the soft tissues about the knee while the skin of the knee is bathed with the sodium carbonate solution.
Whilst it is not intended to be bound to any particular theory, it is believed that the alkalinity of the sodium carbonate solution may have a swelling reduction and/or pain relief benefit. It is also believed that cooling of the soft tissues about the knee resulting from endothermic melting of sodium carbonate decahydrate crystals 24 may contribute to the swelling reduction and/or pain relief benefit. When combined with RICE (rest, ice, compression, and elevation) treatment, it is believed that the controlled and sustained topical release of sodium carbonate solution over and about the skin and soft tissues of the knee may reduce swelling and relieve pain of injury, surgery, or disease.
The embodiments have been described by way of example only and modifications are possible within the scope of the claims which follow.

Claims

1. A body wrap including at least one dosage pack retained on one side of absorbent sheet material having a length sufficient to wrap around a body part, wherein the at least one dosage pack contains a liquefϊable and/or liquefied topical dosage form of sodium carbonate, and wherein wrapping the absorbent sheet material around the body part with the at least one dosage pack against the body part generates a sustained-release topical dosage of sodium carbonate solution which is retained in position around the body part by the absorbent sheet material.
2. A body wrap according to claim 1, wherein the liquefiable and/or liquefied topical dosage form of sodium carbonate is selected from sodium carbonate decahydrate crystals, aqueous solutions of sodium carbonate, flowable compositions of sodium carbonate, and combinations thereof.
3. A body wrap according to claim 1 or 2, wherein the at least one dosage pack has at least one liquid permeable surface or at least one opening through which the sustained- release topical dosage of sodium carbonate solution is released.
4. A body wrap according to claim 3, wherein the at least one liquid permeable surface or at least one opening is selectively liquidly sealed by at least one removable seal.
5. A body wrap according to any preceding claim, wherein the at least one end of the absorbent sheet material has at least one elastic strap to compressively wrap the absorbent sheet material around the body part.
6. A body wrap according to claim 5, wherein the at least one elastic strap is releasably fastenable to itself.
7. A body wrap according to any preceding claim, wherein the absorbent sheet material is rectangular with a length sufficient to wrap around a knee.
PCT/AU2008/000273 2007-03-01 2008-02-29 Body wrap with sodium carbonate dosage pack WO2008104032A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AU2007901059A AU2007901059A0 (en) 2007-03-01 Absorbent poulticing articles
AU2007901059 2007-03-01

Publications (1)

Publication Number Publication Date
WO2008104032A1 true WO2008104032A1 (en) 2008-09-04

Family

ID=39720796

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/AU2008/000273 WO2008104032A1 (en) 2007-03-01 2008-02-29 Body wrap with sodium carbonate dosage pack

Country Status (1)

Country Link
WO (1) WO2008104032A1 (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US6068853A (en) * 1994-04-13 2000-05-30 Novartis Corporation Temporally controlled drug delivery systems
WO2001080797A1 (en) * 2000-04-27 2001-11-01 Hyson Morton I Medicated wrap
WO2002015817A2 (en) * 2000-08-21 2002-02-28 Gelzone, Inc. Flexible support for gel wraps
WO2002019970A1 (en) * 2000-09-08 2002-03-14 Al Siamon Therapeutic topical solution for skin and associated methods of use
WO2006100155A1 (en) * 2005-03-24 2006-09-28 Nolabs Ab Device for wound care, and manufacturing method thereof, involving the use of nitric oxide

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797494A (en) * 1969-04-01 1974-03-19 Alza Corp Bandage for the administration of drug by controlled metering through microporous materials
US3996934A (en) * 1971-08-09 1976-12-14 Alza Corporation Medical bandage
US6068853A (en) * 1994-04-13 2000-05-30 Novartis Corporation Temporally controlled drug delivery systems
WO2001080797A1 (en) * 2000-04-27 2001-11-01 Hyson Morton I Medicated wrap
WO2002015817A2 (en) * 2000-08-21 2002-02-28 Gelzone, Inc. Flexible support for gel wraps
WO2002019970A1 (en) * 2000-09-08 2002-03-14 Al Siamon Therapeutic topical solution for skin and associated methods of use
WO2006100155A1 (en) * 2005-03-24 2006-09-28 Nolabs Ab Device for wound care, and manufacturing method thereof, involving the use of nitric oxide

Similar Documents

Publication Publication Date Title
US7243509B2 (en) Thermal therapeutic method
JP4490971B2 (en) Heating element
US6470705B2 (en) Disposable ice pack
US9644880B2 (en) Cooling device
CA2371471C (en) Absorbent ice bag
US8771331B2 (en) Wrap for applying thermal therapy to a body part
EP2657629A1 (en) Body temperature regulation pack and pack holder for attaching body temperature regulation pack
US20080039810A1 (en) Liquid absorbing cooling pad
US20110029051A1 (en) Upper body thermal relief apparatus and method
WO2001039705A1 (en) Cooling pad
US6602213B1 (en) Disposable splint with instant cold pack
US20060081000A1 (en) Non-slip ice bag device and method for using same to treat patients
EP2813196A1 (en) Method of manufacturing disposable cold pack and related disposable cold pack containing urea and ammonium chloride
MX2009002575A (en) Thermal covering.
JP2002514103A (en) Disposable telescopic warm backpack and method of treating back pain
US20090120126A1 (en) Disposable ice bag
US20120004713A2 (en) Combination tension wrap
WO2008072108A1 (en) Chambered instant cold pack
CA2881580A1 (en) Method of manufacturing disposable cold pack and related disposable cold pack containing phosphate ammonium nitrate
US11931289B2 (en) Universal wrap for securing a thermal pack
JPWO2006006665A1 (en) Exothermic composition and heating element
US20140107739A1 (en) Reusable hot / cold wrap
US6830582B1 (en) Thermal wrap for body member
WO2008104032A1 (en) Body wrap with sodium carbonate dosage pack
US20160228290A1 (en) Personal Cooling Device

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08714325

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08714325

Country of ref document: EP

Kind code of ref document: A1